Is It Really Safe to Discontinue Antiplatelet Therapy 12 Months After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation?

The prevalence of AF in patients with coronary artery disease is high. The guidelines from many professional groups, including the European Society of Cardiology, American College of Cardiology/American Heart Association and Heart Rhythm Society, recommend a maximum duration of 12 months of combinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulrahman, Balen, Jabbour, Richard J, Curzen, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2023
Materias:
Coronary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331563/
https://www.ncbi.nlm.nih.gov/pubmed/37435601
http://dx.doi.org/10.15420/icr.2022.40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331563/
https://www.ncbi.nlm.nih.gov/pubmed/37435601
http://dx.doi.org/10.15420/icr.2022.40

Ejemplares similares